BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29254935)

  • 1. "Future-Proofing" Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical Trials.
    Murray MJ; Watson HL; Ward D; Bailey S; Ferraresso M; Nicholson JC; Gnanapragasam VJ; Thomas B; Scarpini CG; Coleman N
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):208-218. PubMed ID: 29254935
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
    Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ
    World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA.
    Parpart-Li S; Bartlett B; Popoli M; Adleff V; Tucker L; Steinberg R; Georgiadis A; Phallen J; Brahmer J; Azad N; Browner I; Laheru D; Velculescu VE; Sausen M; Diaz LA
    Clin Cancer Res; 2017 May; 23(10):2471-2477. PubMed ID: 27827317
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of long-term storage and freeze-thawing on eight circulating microRNAs in plasma samples.
    Matias-Garcia PR; Wilson R; Mussack V; Reischl E; Waldenberger M; Gieger C; Anton G; Peters A; Kuehn-Steven A
    PLoS One; 2020; 15(1):e0227648. PubMed ID: 31935258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular Analysis.
    Till JE; Black TA; Gentile C; Abdalla A; Wang Z; Sangha HK; Roth JJ; Sussman R; Yee SS; O'Hara MH; Thompson JC; Aggarwal C; Hwang WT; Elenitoba-Johnson KSJ; Carpenter EL
    J Mol Diagn; 2021 Nov; 23(11):1545-1552. PubMed ID: 34454115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows.
    Kloten V; Neumann MHD; Di Pasquale F; Sprenger-Haussels M; Shaffer JM; Schlumpberger M; Herdean A; Betsou F; Ammerlaan W; Af Hällström T; Serkkola E; Forsman T; Lianidou E; Sjöback R; Kubista M; Bender S; Lampignano R; Krahn T; Schlange T;
    Clin Chem; 2019 Sep; 65(9):1132-1140. PubMed ID: 31235535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of circulating tumor DNA stability In K
    Kang Q; Henry NL; Paoletti C; Jiang H; Vats P; Chinnaiyan AM; Hayes DF; Merajver SD; Rae JM; Tewari M
    Clin Biochem; 2016 Dec; 49(18):1354-1360. PubMed ID: 27129799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
    Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
    Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA).
    Gasparello J; Allegretti M; Tremante E; Fabbri E; Amoreo CA; Romania P; Melucci E; Messana K; Borgatti M; Giacomini P; Gambari R; Finotti A
    J Exp Clin Cancer Res; 2018 Jun; 37(1):124. PubMed ID: 29941002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNA profiles in blood plasma from mother-child duos in human biobanks and the implication of sample quality: Circulating miRNAs as potential early markers of child health.
    Dypås LB; Gützkow KB; Olsen AK; Duale N
    PLoS One; 2020; 15(4):e0231040. PubMed ID: 32240265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Robust Protocol to Quantify Circulating Cancer Biomarker MicroRNAs.
    Bell E; Watson HL; Bailey S; Murray MJ; Coleman N
    Methods Mol Biol; 2017; 1580():265-279. PubMed ID: 28439839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples.
    Nesic M; Bødker JS; Terp SK; Dybkær K
    Biomed Res Int; 2021; 2021():5585148. PubMed ID: 34307658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients.
    Schneegans S; Lück L; Besler K; Bluhm L; Stadler JC; Staub J; Greinert R; Volkmer B; Kubista M; Gebhardt C; Sartori A; Irwin D; Serkkola E; Af Hällström T; Lianidou E; Sprenger-Haussels M; Hussong M; Mohr P; Schneider SW; Shaffer J; Pantel K; Wikman H
    Mol Oncol; 2020 May; 14(5):1001-1015. PubMed ID: 32246814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the preanalytical variables affecting the measurement of clinically relevant free-circulating microRNAs: focus on sample matrix, platelet depletion, and storage conditions.
    Faraldi M; Sansoni V; Perego S; Gomarasca M; Kortas J; Ziemann E; Banfi G; Lombardi G
    Biochem Med (Zagreb); 2020 Feb; 30(1):010703. PubMed ID: 31839723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients.
    Risberg B; Tsui DWY; Biggs H; Ruiz-Valdepenas Martin de Almagro A; Dawson SJ; Hodgkin C; Jones L; Parkinson C; Piskorz A; Marass F; Chandrananda D; Moore E; Morris J; Plagnol V; Rosenfeld N; Caldas C; Brenton JD; Gale D
    J Mol Diagn; 2018 Nov; 20(6):883-892. PubMed ID: 30165204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Study of Pre-Analytical Variables and Optimization of Extraction Method for Circulating Tumor DNA Measurements by Digital Droplet PCR.
    Cavallone L; Aldamry M; Lafleur J; Lan C; Gonzalez Ginestet P; Alirezaie N; Ferrario C; Aguilar-Mahecha A; Basik M
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):909-916. PubMed ID: 30824523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of the Anticoagulant Type in Blood Collection Tubes on Circulating Extracellular Plasma MicroRNA Profiles Revealed by Small RNA Sequencing.
    Zhelankin AV; Iulmetova LN; Sharova EI
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Storage Tubes for Combined Analysis of Circulating Nucleic Acids in Liquid Biopsies.
    Ward Gahlawat A; Lenhardt J; Witte T; Keitel D; Kaufhold A; Maass KK; Pajtler KW; Sohn C; Schott S
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in microRNA recovery from plasma: Comparison of five commercial kits.
    Brunet-Vega A; Pericay C; Quílez ME; Ramírez-Lázaro MJ; Calvet X; Lario S
    Anal Biochem; 2015 Nov; 488():28-35. PubMed ID: 26271186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration.
    ElShelmani H; Brennan I; Kelly DJ; Keegan D
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.